Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2018.6371
Abstract: Key Points Question During 2013 to 2016, what proportion of adults were living with hepatitis C virus (HCV) infection in each US state? Findings In this survey study, US national HCV prevalence during 2013 to… read more here.
Keywords: 2013 2016; hepatitis virus; hcv; prevalence ... See more keywords
Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.45424
Abstract: Key Points Question How has the treatment rate for hepatitis C virus infection with direct-acting antivirals (DAAs) changed over time? Findings In this cohort study of 20 277 patients with viremic hepatitis C and private health… read more here.
Keywords: virus infection; treatment rate; hepatitis virus; treatment ... See more keywords
Hepatitis E Virus and Guillain-Barré Syndrome.
Sign Up to like & getrecommendations! Published in 2017 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2016.3651
Abstract: A century ago when Guillain, Barré, and Strohl described the acute inflammatory polyneuropathic syndrome (GuillainBarré syndrome [GBS]) for which they are still eponymously remembered, they noted that, “The pathogenesis of this radiculoneuropathic syndrome cannot be… read more here.
Keywords: hepatitis; hepatitis virus; infection; hev infection ... See more keywords
Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA surgery"
DOI: 10.1001/jamasurg.2022.3922
Abstract: This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications. read more here.
Keywords: reevaluating liver; hepatitis virus; risk; liver donor ... See more keywords
Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus.
Sign Up to like & getrecommendations! Published in 2017 at "Advanced functional materials"
DOI: 10.1002/adfm.201604139
Abstract: The promise of DNA vaccines is far-reaching. However, the development of potent immunization methods remains a key challenge for its use in clinical applications. Here, an approach for in vivo DNA vaccination by electrically activated… read more here.
Keywords: plasmonic nanoparticles; dna vaccination; hepatitis virus;
Cancer risk in patients with hepatitis C virus infection: a population‐based study in Sweden
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Medicine"
DOI: 10.1002/cam4.988
Abstract: Increased risks of certain cancers have been observed in patients with hepatitis C virus (HCV) infection. However, data on other cancer sites/types are lacking. We analyzed systematically the risk of developing 35 common cancers in… read more here.
Keywords: patients hepatitis; infection; hcv infection; hepatitis virus ... See more keywords
Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein–induced hepatocarcinogenesis
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28924
Abstract: Chronic hepatitis B virus infection is a major risk factor for hepatocellular carcinoma (HCC). Hepatitis B virus X protein (HBx) is a hepatitis B virus protein that has multiple cellular functions, but its role in… read more here.
Keywords: hepatology; hepatitis virus; hepatocarcinogenesis; hbx ... See more keywords
Acute hepatitis E virus infection in patients with acute liver failure in China: Not quite an uncommon cause
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28939
Abstract: We have investigated the role of HEV infection in patients with ALF in Nanjing, Jiangsu, China. Our data suggest that acute HEV infection is not an uncommon cause of ALF in a highly endemic region.… read more here.
Keywords: infection patients; acute hepatitis; infection; hepatitis virus ... See more keywords
A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28952
Abstract: Introduction of direct‐acting antivirals against hepatitis C virus (HCV) has provided a revolutionary improvement in the treatment outcome. In contrast to HCV, however, the strategy for developing new antiviral agents against hepatitis B virus (HBV),… read more here.
Keywords: pac; hbv; large surface; hepatitis virus ... See more keywords
Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29008
Abstract: For hepatitis B virus (HBV) e-antigen (HBeAg)-positive chronic hepatitis B (CHB) patients, HBeAg seroconversion is a prerequisite for a definite course of antiviral treatment. Unfortunately, for both entecavir (ETV) and tenofovir disoproxil fumarate (TDF), HBeAg… read more here.
Keywords: antigen hbeag; antiviral therapy; microbiota; hepatitis virus ... See more keywords
Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29095
Abstract: Arecent survey of state Medicaid programs by the Senate Finance Committee revealed that of 68 million Medicaid enrollees in 44 states, nearly 700,000 are positive for the hepatitis C virus (HCV). The advent of new… read more here.
Keywords: state; access; hepatitis virus; medicaid ... See more keywords